UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.92 -0.71 (-0.86%) GOLD FUTURES
2,308.30 -49.40 (-2.10%) DOW
38,037.01 -349.08 (-0.91%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
Akari Therapeutics, Plc (AKTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:49AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 10.14M |
| Enterprise value | 6.30M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.07 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.37 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.96 |
| 52-week change 3 | -65.03% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 5.5000 |
| 52-week low 3 | 1.0780 |
| 50-day moving average 3 | 1.7677 |
| 200-day moving average 3 | 2.9899 |
Share statistics
| Avg vol (3-month) 3 | 12.09k |
| Avg vol (10-day) 3 | 9.71k |
| Shares outstanding 5 | 7.92M |
| Implied shares outstanding 6 | 5.06M |
| Float 8 | 9.56B |
| % held by insiders 1 | 17.91% |
| % held by institutions 1 | 1.61% |
| Shares short (15 Apr 2024) 4 | 575 |
| Short ratio (15 Apr 2024) 4 | 0.03 |
| Short % of float (15 Apr 2024) 4 | 0.01% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.01% |
| Shares short (prior month 15 Mar 2024) 4 | 5.95k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 17 Aug 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -115.51% |
| Return on equity (ttm) | -1,281.43% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -16.8M |
| Net income avi to common (ttm) | -10.01M |
| Diluted EPS (ttm) | -2.0400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.85M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.95 |
| Book value per share (mrq) | -0.04 |
Cash flow statement
| Operating cash flow (ttm) | -16.43M |
| Levered free cash flow (ttm) | -16.74M |
© 2024 Yahoo. All rights reserved.